Search Results

Findings shows animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB meningitis.
Biotechnology

FDA-Approved TB Regimen May Not Work Against Deadliest Form of TB Due to Multidrug-Resistant Strains

MBT Desk
3 min read
Tuberculosis, caused by the bacteria Mycobacterium tuberculosis, is a global public health threat. According to the WHO, it is one of the leading killers by a single infectious agent.
Image of a capsules of red and white color in hands of a person wearing surgical gloves along with graphics of bacteria.
India

Prevalence of Multidrug-Resistant Organisms Highest in Indian Patients: Study

MBT Desk
2 min read
A Lancet eClinical Medicine study warns that India is the global hotspot of multidrug-resistant organisms, calling for urgent antibiotic stewardship reforms.
The Joint Panel comprised 25 global experts in pulmonary medicine, infectious diseases, pediatrics, epidemiology, and public health (Representational Image: Freepik)
Medicine

New Guidelines for Drug-Susceptible and Drug-Resistant TB: Shorter, Safer and All-Oral Regimens

Dr. Disha Merlyn Mathias
3 min read
An official update in the treatment of both drug-susceptible and drug-resistant TB by the international panel of experts: ATS/CDC/ERS/IDSA
BPaL’s 6-month regimen for drug-resistant TB to be launched nationwide in January after training sessions conclude. (Wikimedia Commons)
Medicine

National TB Elimination Programme Prepares for Launch of Shortest Drug-Resistant TB Treatment BPaL

Ankur Deka
2 min read
Six-month regimen expected to improve treatment outcomes; training sessions underway for doctors across Indian states
India introduced the BPaLM regimen for MDR-TB, which includes Bedaquiline, Pretomanid, Linezolid, and (with or without) Moxifloxacin. It is a newer, shorter regimen, often completed in less than 6 months. ( Representational image : Unsplash )
Medicine

India Targets TB Elimination By 2025: New BPaLM Regimen For Drug-Resistant TB

Yash Kiran Kamble
3 min read
Tuberculosis (TB) remains one of the world's deadliest infectious diseases, particularly in developing regions
Antibiotics have been invaluable in the fight against bacterial infections, but bacteria are becoming more and more resistant to them
Fitness and Wellness

A New Treatment for Multidrug-Resistant Bacteria

MBT Desk
3 min read
A new type of drug could provide a way to treat multidrug-resistant bacteria, according to a study published in Nature Communications.
Read More
logo
Medbound Times
www.medboundtimes.com